ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,256, issued on March 17, was assigned to Nogra Pharma Ltd. (Dublin).
"Aryl receptor modulators and methods of making and using the same" was invented by Francesca Viti (Salorino, Switzerland), Salvatore Bellinvia (Mendrisio, Switzerland) and Salvatore Demartis (Milan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is generally directed towards compounds capable of binding the aryl hydrocarbon receptor and modulating its activity, methods of treating inflammatory conditions such as Crohn's disease using such compounds, and pharmaceutical compositions comprising such compounds. Also provided are methods of increasing levels of IL...